Company: Wave 80 Biosciences
Larta Program: NIH-CAP
City: San Francisco, California
Problem: The limited resources and high cost of infectious disease monitoring & diagnostics, especially in targeted resource constrained regions including China & African nations.
Solution: Daniel makes next-generation molecular diagnostics instruments for HIV/AIDS, hepatitis and other human health conditions more accessible by keeping costs 25-60% lower than comparable systems.
Success: While working with Larta, Daniel secured a $1 million angel financing round. He stated “Our Larta mentor provided highly valuable feedback on our corporate strategy, presentation, and fundraising program.” Since completing his Larta program, Daniel continues to work closely with his Larta mentor.